T cell subsets and cellular immunity in end-stage renal disease - PubMed (original) (raw)
T cell subsets and cellular immunity in end-stage renal disease
K Raska Jr et al. Am J Med. 1983 Nov.
Abstract
The T lymphocyte population was studied by immunofluorescent staining with monoclonal antibodies and laser flow cytometry in the blood of 50 patients with end-stage renal disease undergoing long-term maintenance intermittent hemodialysis. The absolute number of T cells was lower in patients receiving dialysis for more than one year (p less than 0.001), as was the absolute count of helper T cells (p less than 0.005). In patients under 30 years of age, the absolute number of helper T cells was markedly reduced, whereas the number of suppressor/cytotoxic T lymphocytes was not changed. In patients between the ages of 30 and 60 years, both helper and suppressor cells were significantly reduced. In patients over 60 years of age, only the number of helper T cells was reduced. The in vitro response of patients' lymphocytes was reduced both in the mixed lymphocyte reaction (p less than 0.01) and after phytohemagglutinin stimulation (p less than 0.001). Natural killer cytotoxicity of patients' peripheral blood mononuclear cells, however, was unaffected.
Similar articles
- Cellular immunity and lymphocyte populations in developing uremia in the rat.
Raskova J, Czerwinski DK, Shea SM, Raska K Jr. Raskova J, et al. J Exp Pathol. 1986 Summer;2(4):229-45. J Exp Pathol. 1986. PMID: 2946817 - T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
Raskova J, Ghobrial I, Shea SM, Ebert EC, Eisinger RP, Raska K Jr. Raskova J, et al. Diagn Immunol. 1986;4(4):209-16. Diagn Immunol. 1986. PMID: 2944684 - Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients.
Nanishi F, Inenaga T, Onoyama K, Oh Y, Oochi N, Fujishima M. Nanishi F, et al. J Clin Lab Immunol. 1986 Apr;19(4):167-74. J Clin Lab Immunol. 1986. PMID: 2941588 - Immunomodulation and biomaterials.
Tetta C, Camussi G, Mariano F, Triolo G, Vercellone A. Tetta C, et al. Biomater Artif Cells Immobilization Biotechnol. 1993;21(2):253-63. doi: 10.3109/10731199309117362. Biomater Artif Cells Immobilization Biotechnol. 1993. PMID: 8318617 Review. No abstract available. - The immune system in end-stage renal disease.
Descamps-Latscha B. Descamps-Latscha B. Curr Opin Nephrol Hypertens. 1993 Nov;2(6):883-91. doi: 10.1097/00041552-199311000-00005. Curr Opin Nephrol Hypertens. 1993. PMID: 7922228 Review.
Cited by
- Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach.
Lamarche C, Iliuta IA, Kitzler T. Lamarche C, et al. Can J Kidney Health Dis. 2019 Apr 29;6:2054358119839080. doi: 10.1177/2054358119839080. eCollection 2019. Can J Kidney Health Dis. 2019. PMID: 31065378 Free PMC article. Review. - The lungs in uraemia: a review.
Bush A, Gabriel R. Bush A, et al. J R Soc Med. 1985 Oct;78(10):849-55. doi: 10.1177/014107688507801012. J R Soc Med. 1985. PMID: 3930725 Free PMC article. Review. No abstract available. - Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease.
Kao CC, Wu VC, Sun HY, Wu CH; NSARF Group. Kao CC, et al. Int Urol Nephrol. 2013 Oct;45(5):1505-9. doi: 10.1007/s11255-012-0196-y. Epub 2012 May 25. Int Urol Nephrol. 2013. PMID: 22627787 - The use of vaccines in renal failure.
Johnson DW, Fleming SJ. Johnson DW, et al. Clin Pharmacokinet. 1992 Jun;22(6):434-46. doi: 10.2165/00003088-199222060-00003. Clin Pharmacokinet. 1992. PMID: 1587056 Review. - Effect of uremia on structure and function of immune system.
Vaziri ND, Pahl MV, Crum A, Norris K. Vaziri ND, et al. J Ren Nutr. 2012 Jan;22(1):149-56. doi: 10.1053/j.jrn.2011.10.020. J Ren Nutr. 2012. PMID: 22200433 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical